相关实验视频
Updated: Jun 23, 2025

05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.0K
在预测生物标志物的小型研究中,考克斯比例危险回归
K Jóźwiak1, V H Nguyen2,3, L Sollfrank2
1Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Fehrbelliner Straße 39, 16816, Neuruppin, Germany. katarzyna.jozwiak@mhb-fontane.de.
Scientific reports
|June 20, 2024
概括
调查预测生物标志物的小型研究往往产生有偏见的结果. 经过修改的Cox模型与Firth校正和概率概率置信区间 (CI) 改善了个性化医学研究的准确性和功率.
科学领域:
- 生物统计学 生物统计学
- 临床研究 临床研究
- 个性化医疗是个性化的医疗.
背景情况:
- 预测生物标志物对于个性化医疗至关重要,指导治疗选择.
- 由于小型研究的局限性,很少有评估的生物标志物进入临床实践.
- 在小型研究中,标准的统计方法可能会导致偏差和低功率.
研究的目的:
- 为了评估标准的考克斯比例危险模型对预测生物标志物的小样本行为.
- 评估Firth校正和概率概率信心区间 (CI) 作为补救措施的有效性.
主要方法:
- 进行了一项模拟研究,以评估Cox模型在小样本大小的表现.
- 在考克斯模型的得分函数中应用了Firth校正.
- 使用概率概率 (PL) 方法生成置信区间.
主要成果:
- 标准考克斯模型在估计生物标志物治疗相互作用和子组内治疗效应时表现出偏差.
- 标准错误被标准考克斯模型高估了.
- 正和PL CIs减少了偏差,增加了统计能力.
结论:
- 标准的Cox模型与基于Wald的CI对于预测生物标志物的小型研究是不可靠的.
- 对于小规模生物标志物研究,建议采用包含Firth校正和PL CIs的修改后的Cox模型.
- 这些改进的方法提高了个性化医学中预测生物标志物评估的可靠性.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Comparing the Survival Analysis of Two or More Groups
177
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177
The Mantel-Cox Log-Rank Test
347
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
347
Hazard Ratio
111
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
111
Hazard Rate
102
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
102
Assumptions of Survival Analysis
121
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
121

